Results 101 to 110 of about 1,359,849 (169)

[Long-term course of immunosuppressive therapy of Vogt-Koyanagi-Harada syndrome].

, 2015
This article describes the case of a 22-year old female patient, who first presented with holocephalic headaches and bilateral loss in vision. After diagnosis of a complete Vogt-Koyanagi-Harada syndrome, high-dose corticosteroid therapy was initiated ...
Wand, K;Abraham, S;Loos, D;Stumpfe, S;Lohmann, C;Maier, M;Feucht, N
core   +1 more source

Vogt-Koyanagi-Harada syndrome in the setting of COVID-19 infection. [PDF]

Clin Case Rep, 2023
Eatz T, Charles JH.
europepmc   +1 more source

Síndrome uveo meníngeo de Vogt-Koyanagi- Harada. A propósito de un caso [PDF]

, 2015
Objetivo: Reportar un caso de Síndrome de Vogt-Koyanagi-Harada y describir las características clínicasdel cuadro.Diseño: Reporte de caso único, intervencionistaMétodos: Presentación de las características clínicasdel caso.Resultados: Se presenta un caso
Ayala Haedo, Luis; Hospital de Clínicas. FCM, UNA, Casco, Ingrid; Hospital de Clínicas. FCM, UNA, Cibils, Pablo; Hospital de Clínicas. FCM, UNA, Carron Alvarado, Agustín; Hospital de Clínicas. FCM, UNA   +3 more
core  

Intravitreal triamcinolone for intraocular inflammation and associated macular edema

Clinical Ophthalmology, 2008
Steven M Couch, Sophie J BakriMayo Clinic Department of Ophthalmology, Mayo Clinic, Rochester, MN, USAAbstract: Triamcinolone acetonide (TA) is a corticosteroid that has many uses in the treatment of ocular diseases because of its potent anti ...
Steven M Couch, Sophie J Bakri
doaj  

Vogt–Koyanagi–Harada (VKH)—What Do We Know About the Disease, and Can We Recognize It?

Diagnostics
Background: Vogt–Koyanagi–Harada (VKH) is a multisystem autoimmune disease that ophthalmologists often encounter first. The condition is caused by an immune response against tyrosinase-related proteins in pigment cells (melanocytes) of the uvea, inner ...
Maria Boyadzhieva, Preslava Encheva, Dobrin Boyadzhiev, Valeri Sheherov, Darina Koseva, Zornitsa Zlatarova   +5 more
doaj   +1 more source

Successive onset of Vogt-Koyanagi-Harada syndrome in father and son. [PDF]

BMC Ophthalmol, 2023
Li H, Sun S, Zhang Y, Liu J, Zhao X, Zhao G.   +5 more
europepmc   +1 more source

Ocular syphilis mimicking Vogt-Koyanagi-Harada syndrome: a diagnostic dilemma. [PDF]

Proc (Bayl Univ Med Cent), 2023
Abdelnabi M, Rimu A, Siddiqui S, Mora B, Guerin C.   +4 more
europepmc   +1 more source

Vogt-Koyanagi-Harada Syndrome in Two Patients with Immunoglobulin A Nephropathy

We describe herein 2 patients who developed Vogt-Koyanagi-Harada syndrome in the course of renal biopsy-proven immunoglobulin A (IgA) nephropathy. A 61-year-old man with an 11-year history of IgA nephropathy and a 16-year history of thyroiditis, and a 56-
Ota, Kosuke, Masuda, Ikuya, Nose, Soichiro, Sunami, Reiko, Yamadori, Ichiro, Matsuo, Toshihiko   +5 more
core  

Auditory and vestibular manifestations of Vogt–Koyanagi–Harada disease

, 2010
Introduction and aims:Vogt–Koyanagi–Harada disease is a chronic disorder involving the eye and the central nervous, auditory, vestibular and integumentary systems.
S Al Dousary
core   +1 more source

Vogt-Koyanagi-Harada disease.

, 2019
Vogt-Koyanagi-Harada disease is a rare, multisystem, autoimmune disorder with numerous clinical manifestations, mediated through a T-helper 1 response against melanocytes in the eye, inner ear, central nervous system, hair and skin. We describe a 20-year-
Mollan, Susan P, Sreekantam, Sreekanth, Sivaguru, Arul, Street, Duncan   +3 more
core   +1 more source